Contrast-enhanced magnetic resonance imaging (CE-MRI) monitoring across multiple time points is critical for optimizing hepatocellular carcinoma (HCC) prognosis during transarterial chemoembolization (TACE) treatment. The aim of this retrospective study is to develop and validate an artificial intelligence (AI)-powered models utilizing multi-time-point arterial phase CE-MRI data for HCC prognosis stratification in TACE patients. A total of 543 individual arterial phase CE-MRI scans from 181 HCC patients were retrospectively collected in this study. All patients underwent TACE and longitudinal arterial phase CE-MRI assessments at three time points: prior to treatment, and following the first and second TACE sessions. Among them, 110 patients received TACE monotherapy, while the remaining 71 patients underwent TACE in combination with microwave ablation (MWA). All images were subjected to standardized preprocessing procedures. We developed an end-to-end deep learning model, ProgSwin-UNETR, based on the Swin Transformer architecture, to perform four-class prognosis stratification directly from input imaging data. The model was trained using multi-time-point arterial phase CE-MRI data and evaluated via fourfold cross-validation. Classification performance was assessed using the area under the receiver operating characteristic curve (AUC). For comparative analysis, we benchmarked performance against traditional radiomics-based classifiers and the mRECIST criteria. Prognostic utility was further assessed using Kaplan-Meier (KM) survival curves. Additionally, multivariate Cox proportional hazards regression was performed as a post hoc analysis to evaluate the independent and complementary prognostic value of the model outputs and clinical variables. GradCAM +  + was applied to visualize the imaging regions contributing most to model prediction. The ProgSwin-UNETR model achieved an accuracy of 0.86 and an AUC of 0.92 (95% CI: 0.90-0.95) for the four-class prognosis stratification task, outperforming radiomic models across all risk groups. Furthermore, KM survival analyses were performed using three different approaches-AI model, radiomics-based classifiers, and mRECIST criteria-to stratify patients by risk. Of the three approaches, only the AI-based ProgSwin-UNETR model achieved statistically significant risk stratification across the entire cohort and in both TACE-alone and TACE + MWA subgroups (p < 0.005). In contrast, the mRECIST and radiomics models did not yield significant survival differences across subgroups (p > 0.05). Multivariate Cox regression analysis further demonstrated that the model was a robust independent prognostic factor (p = 0.01), effectively stratifying patients into four distinct risk groups (Class 0 to Class 3) with Log(HR) values of 0.97, 0.51, -0.53, and -0.92, respectively. Additionally, GradCAM +  + visualizations highlighted critical regional features contributing to prognosis prediction, providing interpretability of the model. ProgSwin-UNETR can well predict the various risk groups of HCC patients undergoing TACE therapy and can further be applied for personalized prediction.

Medical image segmentation is a complex and challenging task, which aims to accurately segment various structures or abnormal regions in medical images. However, obtaining accurate segmentation results is difficult because of the great uncertainty in the shape, location, and scale of the target region. To address these challenges, we propose a higher-order spatial interaction framework with dual cross global efficient attention (DGEAHorNet), which employs a neural network architecture based on recursive gate convolution to adequately extract multi-scale contextual information from images. Specifically, a Dual Cross-Attentions (DCA) is added to the skip connection that can effectively blend multi-stage encoder features and narrow the semantic gap. In the bottleneck stage, global channel spatial attention module (GCSAM) is used to extract image global information. To obtain better feature representation, we feed the output from the GCSAM into the multi-branch dense layer (SENetV2) for excitation. Furthermore, we adopt Depthwise Over-parameterized Convolutional Layer (DO-Conv) in order to replace the common convolutional layer in the input and output part of our network, then add Efficient Attention (EA) to diminish computational complexity and enhance our model's performance. For evaluating the effectiveness of our proposed DGEAHorNet, we conduct comprehensive experiments on four publicly-available datasets, and achieving 0.9320, 0.9337, 0.9312 and 0.7799 in Dice similarity coefficient on ISIC2018, ISIC2017, CVC-ClinicDB and HRF respectively. Our results show that DGEAHorNet has better performance compared with advanced methods. The code is publicly available at https://github.com/penghaixin/mymodel .

Leveraging the powerful capabilities of diffusion models has yielded quite effective results in medical image segmentation tasks. However, existing methods typically transfer the original training process directly without specific adjustments for segmentation tasks. Furthermore, the commonly used pre-trained diffusion models still have deficiencies in feature extraction. Based on these considerations, we propose LEAF, a medical image segmentation model grounded in latent diffusion models. During the fine-tuning process, we replace the original noise prediction pattern with a direct prediction of the segmentation map, thereby reducing the variance of segmentation results. We also employ a feature distillation method to align the hidden states of the convolutional layers with the features from a transformer-based vision encoder. Experimental results demonstrate that our method enhances the performance of the original diffusion model across multiple segmentation datasets for different disease types. Notably, our approach does not alter the model architecture, nor does it increase the number of parameters or computation during the inference phase, making it highly efficient.

Anomaly detection in medical images is an important yet challenging task due to the diversity of possible anomalies and the practical impossibility of collecting comprehensively annotated data sets. In this work, we tackle unsupervised medical anomaly detection proposing a modernized autoencoder-based framework, the Q-Former Autoencoder, that leverages state-of-the-art pretrained vision foundation models, such as DINO, DINOv2 and Masked Autoencoder. Instead of training encoders from scratch, we directly utilize frozen vision foundation models as feature extractors, enabling rich, multi-stage, high-level representations without domain-specific fine-tuning. We propose the usage of the Q-Former architecture as the bottleneck, which enables the control of the length of the reconstruction sequence, while efficiently aggregating multiscale features. Additionally, we incorporate a perceptual loss computed using features from a pretrained Masked Autoencoder, guiding the reconstruction towards semantically meaningful structures. Our framework is evaluated on four diverse medical anomaly detection benchmarks, achieving state-of-the-art results on BraTS2021, RESC, and RSNA. Our results highlight the potential of vision foundation model encoders, pretrained on natural images, to generalize effectively to medical image analysis tasks without further fine-tuning. We release the code and models at https://github.com/emirhanbayar/QFAE.

EDM elucidates the unified design space of diffusion models, yet its fixed noise patterns restricted to pure Gaussian noise, limit advancements in image restoration. Our study indicates that forcibly injecting Gaussian noise corrupts the degraded images, overextends the image transformation distance, and increases restoration complexity. To address this problem, our proposed EDA Elucidates the Design space of Arbitrary-noise-based diffusion models. Theoretically, EDA expands the freedom of noise pattern while preserving the original module flexibility of EDM, with rigorous proof that increased noise complexity incurs no additional computational overhead during restoration. EDA is validated on three typical tasks: MRI bias field correction (global smooth noise), CT metal artifact reduction (global sharp noise), and natural image shadow removal (local boundary-aware noise). With only 5 sampling steps, EDA outperforms most task-specific methods and achieves state-of-the-art performance in bias field correction and shadow removal.

Thyroid incidentalomas (TIs) are incidental thyroid lesions detected on fluorodeoxy-d-glucose (18F-FDG) PET/computed tomography (PET/CT) scans. This study aims to investigate the role of noninvasive PET/CT-derived radiomic features in characterizing 18F-FDG PET/CT TIs and distinguishing benign from malignant thyroid lesions in oncological patients. We included 46 patients with PET/CT TIs who underwent thyroid ultrasound and thyroid surgery at our oncological referral hospital. Radiomic features extracted from regions of interest (ROI) in both PET and CT images and analyzed for their association with thyroid cancer and their predictive ability. The TIs were graded using the ultrasound TIRADS classification, and histopathological results served as the reference standard. Univariate and multivariate analyses were performed using features from each modality individually and combined. The performance of radiomic features was compared to the TIRADS classification. Among the 46 included patients, 36 patients (78%) had malignant thyroid lesions, while 10 patients (22%) had benign lesions. The combined run length nonuniformity radiomic feature from PET and CT cubical ROIs demonstrated the highest area under the curve (AUC) of 0.88 (P < 0.05), with a negative correlation with malignancy. This performance was comparable to the TIRADS classification (AUC: 0.84, P < 0.05), which showed a positive correlation with thyroid cancer. Multivariate analysis showed higher predictive performance using CT-derived radiomics (AUC: 0.86 ± 0.13) compared to TIRADS (AUC: 0.80 ± 0.08). This study highlights the potential of 18F-FDG PET/CT-derived radiomics to distinguish benign from malignant thyroid lesions. Further studies with larger cohorts and deep learning-based methods could obtain more robust results.

Percutaneous transluminal angioplasty and stenting (PTAS) in patients with carotid stenosis may have potential effects on brain parenchyma. However, current studies on parenchymal changes are scarce due to the need for advanced imaging modalities. Consequently, the alterations in brain parenchyma following PTAS remain an unsolved issue. To investigate changes to the brain parenchyma using magnetic resonance elastography (MRE). Prospective. 13 patients (6 women and 7 men; 39 MRI imaging sessions) with severe unilateral carotid stenosis patients indicated for PTAS were recruited between 2021 and 2024. Noncontrast MRI sequences including MRE (spin echo) were acquired using 3 T scanners. All patients underwent MRE before (preprocedural), within 24 h (early postprocedural) and 3 months after (delayed postprocedural) PTAS. Preprocedural and delayed postprocedural ultrasonographic peak systolic velocity (PSV) was recorded. MRE stiffness and damping ratio were evaluated via neural network inversion of the whole brain, in 14 gray matter (GM) and 12 white matter (WM) regions. Stiffness and damping ratio differences between each pair of MR sessions for each subject were identified by paired sample t tests. The correlations of stiffness and damping ratio with stenosis grade and ultrasonographic PSV dynamics were evaluated by Pearson correlation coefficients. The statistical significance was defined as p < 0.05. The stiffness of lesion side insula, deep GM, and deep WM increased significantly from preprocedural to delayed postprocedural MRE. Increasing deep GM stiffness on the lesion side was positively correlated with the DSA stenosis grade significantly (r = 0.609). The lesion side insula stiffness increments were positively correlated with PSV decrements significantly (r = 0.664). Regional brain stiffness increased 3 months after PTAS. Lesion side stiffness was positively correlated with stenosis grades in deep GM and PSV decrements in the insula. EVIDENCE LEVEL: 2. Stage 2.

The goal of this study was to develop a highly precise, dynamic machine learning model centered on daily transcranial Doppler ultrasound (TCD) data to predict angiographic vasospasm (AV) in the context of aneurysmal subarachnoid hemorrhage (aSAH). A retrospective review of patients with aSAH treated at a single institution was performed. The primary outcome was AV, defined as angiographic narrowing of any intracranial artery at any time point during admission from risk assessment. Standard demographic, clinical, and radiographic data were collected. Quantitative data including mean arterial pressure, cerebral perfusion pressure, daily serum sodium, and hourly ventriculostomy output were collected. Detailed daily TCD data of intracranial arteries including maximum velocities, pulsatility indices, and Lindegaard ratios were collected. Three predictive machine learning models were created and compared: A static multivariate logistics regression model based on data collected on the date of admission (Baseline Model; BM), a standard TCD model using middle cerebral artery flow velocity and Lindegaard ratio measurements (SM), and a machine learning long short term memory (LSTM) model using all data trended through the hospitalization. A total of 424 patients with aSAH were reviewed, 78 of whom developed AV. In predicting AV at any time point in the future, the LSTM model had the highest precision (0.571) and accuracy (0.776), whereas the SM model had the highest overall performance with an F1 score of 0.566. In predicting AV within 5 days, the LSTM continued to have the highest precision (0.488) and accuracy (0.803). After an ablation test removing all non-TCD elements, the LSTM model improved to a precision of 0.824. Longitudinal TCD data can be used to create a dynamic machine learning model with higher precision than static TCD measurements for predicting AV after aSAH.

Artificial intelligence (AI) is rapidly transforming health care, offering potential benefits in diagnosis, treatment, and workflow efficiency. However, limited research explores patient perspectives on AI, especially in its role in diagnosis and communication. This study examines patient perceptions of various AI applications, focusing on the diagnostic process and communication. This study aimed to examine patient perspectives on AI use in health care, particularly in diagnostic processes and communication, identifying key concerns, expectations, and opportunities to guide the development and implementation of AI tools. This study used a qualitative focus group methodology with co-design principles to explore patient and family member perspectives on AI in clinical practice. A single 2-hour session was conducted with 17 adult participants. The session included interactive activities and breakout sessions focused on five specific AI scenarios relevant to diagnosis and communication: (1) portal messaging, (2) radiology review, (3) digital scribe, (4) virtual human, and (5) decision support. The session was audio-recorded and transcribed, with facilitator notes and demographic questionnaires collected. Data were analyzed using inductive thematic analysis by 2 independent researchers (GF and JB), with discrepancies resolved via consensus. Participants reported varying comfort levels with AI applications contingent on the level of patient interaction, with digital scribe (average 4.24, range 2-5) and radiology review (average 4.00, range 2-5) being the highest, and virtual human (average 1.68, range 1-4) being the lowest. In total, five cross-cutting themes emerged: (1) validation (concerns about model reliability), (2) usability (impact on diagnostic processes), (3) transparency (expectations for disclosing AI usage), (4) opportunities (potential for AI to improve care), and (5) privacy (concerns about data security). Participants valued the co-design session and felt they had a significant say in the discussions. This study highlights the importance of incorporating patient perspectives in the design and implementation of AI tools in health care. Transparency, human oversight, clear communication, and data privacy are crucial for patient trust and acceptance of AI in diagnostic processes. These findings inform strategies for individual clinicians, health care organizations, and policy makers to ensure responsible and patient-centered AI deployment in health care.

The differentiation between multiple system atrophy (MSA) and Parkinson's disease (PD) based on clinical diagnostic criteria can be challenging, especially at an early stage. Leveraging deep learning methods and magnetic resonance imaging (MRI) data has shown great potential in aiding automatic diagnosis. The aim was to determine the feasibility of a three-dimensional convolutional neural network (3D CNN)-based approach using multimodal, multicentric MRI data for differentiating MSA and its variants from PD. MRI data were retrospectively collected from three MSA French reference centers. We computed quantitative maps of gray matter density (GD) from a T1-weighted sequence and mean diffusivity (MD) from diffusion tensor imaging. These maps were used as input to a 3D CNN, either individually ("monomodal," "GD" or "MD") or in combination ("bimodal," "GD-MD"). Classification tasks included the differentiation of PD and MSA patients. Model interpretability was investigated by analyzing misclassified patients and providing a visual interpretation of the most activated regions in CNN predictions. The study population included 92 patients with MSA (50 with MSA-P, parkinsonian variant; 33 with MSA-C, cerebellar variant; 9 with MSA-PC, mixed variant) and 64 with PD. The best accuracies were obtained for the PD/MSA (0.88 ± 0.03 with GD-MD), PD/MSA-C&PC (0.84 ± 0.08 with MD), and PD/MSA-P (0.78 ± 0.09 with GD) tasks. Patients misclassified by the CNN exhibited fewer and milder image alterations, as found using an image-based z score analysis. Activation maps highlighted regions involved in MSA pathophysiology, namely the putamen and cerebellum. Our findings hold promise for developing an efficient, MRI-based, and user-independent diagnostic tool suitable for differentiating parkinsonian syndromes in clinical practice. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.